Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 81 results for "novartis india"

Experts say Sun Pharma chairman best man to steer Ranbaxy out of its distress
Times of India

Experts say Sun Pharma chairman best man to steer Ranbaxy out ...

MUMBAI: From assisting his father in the wholesale generic drugs business to starting his own psychiatric drug manufacturing company in 1983 with just a few thousand rupees, and then going on to become the owner of the world's fifth largest generics ... Pharmacy Choice, 1 week ago

34 images for novartis india

Yahoo! News Australia, 1 week ago
4 Traders, 1 week ago
Sky News Australia, 2 weeks ago
Digital Journal, 2 weeks ago
Pharmafocus, 2 weeks ago, 1 month ago, 1 month ago
BDlive, 1 month ago
4 Traders, 1 month ago
VOA News, 1 month ago

Stocks as on April 17, 2014

Data for 800 companies from Bombay Stock Exchange. Values are: days closing price, previous closing price in brackets, 52-week low and high in bold, and volume traded (in 000) in brackets. GROUP A A A B B 847.8(831.6) 869-448 (57) A C C 1360.55(1332.4) ...
 Deccan Herald2 days ago Stocks as on April 16, 2014  Deccan Herald3 days ago Stocks as on April 14, 2014  Deccan Herald6 days ago Stocks as on March 22, 2014  Deccan Herald4 weeks ago

Will Sun Rise Again?

Anyone monitoring Ranbaxy's shareholding pattern in December 2013 would have noticed a new entrant by the name of Silverstreet Developers with a 1.41% stake in the Daiichi Sankyo subsidiary. By March, the same entity had further raised its stake to ...
 Outlookbusiness.com6 days ago

Stocks as on 9 April, 2014

GROUP A A A B B 839.15(822.45) 869-448 (16) A C C 1372.05(1379.9) 1399-912 (44) Abg Shipyard 256.95(256.4) 357-227 (40) Abirlanuv 1100.0(1088.65) 1290-930 (11) Acl 210.1(208.75) 211-147 (111) Adani Enter 381.85(377.95) 386-126 (298) Allahabad Bank 95.3(91.7) ...
 Deccan Herald1 week ago

Dilip Shanghvi, Sun Pharma promoter, a pharma maven with midas touch

MUMBAI: Dilip S Shanghvi, the 57-year-old founder of , studied commerce. But he can stand his ground against research scientists in his industry on therapeutic areas or even different pathways to get to the same molecule. He is a voracious reader ...
 Economic Times1 week ago

Works well for all players

These were highly distressed assets and it works out well for all the players. Daiichi is out of it, Sun has an uncut diamond and the Singh brothers can heave a sigh of relief! Dilip Shanghvi has come as a knight in shining armour and has won the ...
 Hindu Business Line1 week ago

Novartis sues Biocon for patent infringement on Galvus

I Glavus is also marketed in combination with Metformin Hydrochloride, owned by Novartis in India. Novartis's case stems from the fact that Biocon had sought & received approval from the Indian drug regulator CDSCO for its version of ...
 Moneycontrol.com2 weeks ago Novartis files patent suit against Biocon over diabetes drug  Smart Investor2 weeks ago Novartis sues Biocon for patent breach  Smart Investor2 weeks ago
Finance 24

Indian quality woes point to generic drugs shake-out: Novartis

Related to : Novartis India Ltd Novartis India Ltd BSE 20 Mar 14 | 12:00 AM 412.35 -3.75 (-0.9%) NSE 01 Jan 70 | 05:30 AM 0.00 0 (0%) Recent manufacturing problems in India suggest some makers of generic drugs will struggle to ...
 Smart Investor1 month ago US fears for patents on drugs in India  Finance 241 month ago U.S. fears for patents on next-gen drugs in India  Reuters India1 month ago US fears for patents on next-generation drugs in India  Reuters1 month ago
Business Standard India

Novartis may be fined for submitting fake document to Drug Controller General of India

NEW DELHI: Swiss drug innovator firm Novartis may face penalties in India for submitting 'fake' document to the (DCGI) for a veterinary medicine. The Indian arm of Novartis has admitted before the DCGI that it had submitted a document that was later ...
 Economic Times1 month ago Novartis might face legal action, penalty for faking documents  Business Standard India1 month ago Why is Novartis likely to lose Tiamulin drug licence?  Rediff.com1 month ago
Business Standard

Novartis India standalone Dec '13 sales at Rs 224.64 crore

Novartis India has reported a sales standalone turnover of Rs 224.64 crore and a net profit of Rs 15.23 crore for the quarter ended Dec '13
 Money Control2 months ago Novartis India Q3 net down 47 pc at Rs 15.23 crore  Business Standard2 months ago Novartis India Q3 net down 47% at Rs 15 crore  Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less